MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2023 International Congress

    Diplopia (Double vision) in Parkinson’s disease patients: prevalence and nonmotor effect

    EL. Ungureanu, KR. Chaudhuri, ș. Diaconu, L. Irincu, R. Filip, B. Ciopleiaș, C. Falup-Pecurariu (Brasov, Romania)

    Objective: To assess the prevalence of diplopia in Parkinson’s disease (PD) patients and the correlation of diplopia with visual hallucinations, cognitive dysfunction and motor performance.…
  • 2023 International Congress

    PDQ-39 predicts quality of life improvement following neurostimulation for Parkinson’s disease: Prospective observational study

    L. Torrão, M. Rosas, J. Massano, A. Oliveira, C. Chamadoira, M. Rito, J. Guimarães, C. Soares (Póvoa de Varzim, Portugal)

    Objective: The primary outcome was assessing QoL of a cohort of patients with PD before and after undergoing DBS surgery, measured using PDQ-39 questionary. Secondary…
  • 2023 International Congress

    PD-PROP reporting in participants own words shows high burden of cognitive symptoms in early Parkinson Disease (PD)

    J. Purks, L. Arbatti, A. Hosamath, A. Amara, K. Anderson, L. Chahine, S. Eberly, D. Kinel, S. Mantri, S. Mathur, D. Oakes, D. Standaert, D. Weintraub, I. Shoulson, C. Marras (Rochester, USA)

    Objective: Describe the relative frequency of bothersome cognitive symptoms reported verbatim by people with PD in the Fox Insight online study. Background: Cognitive decline is…
  • 2023 International Congress

    Performance of commercial EEG wearable for sleep classification in Parkinson disease

    D. González, D. Wang, E. Pollet, A. Velarde, S. Horn, J. Ramirez-Castaneda, P. Coss, O. Vaou, J. Wang, C. Li, S. Seshadri, H. Miao, M. Gonzales (Chicago, USA)

    Objective: To evaluate the performance of a consumer-grade EEG device compared against polysomnography (PSG) in individuals with Parkinson’s disease (PD). Background: Sleep disturbance is an…
  • 2023 International Congress

    Aspects of early detection of parkinson`s disease in ambulatory settings

    R. Matmurodov, B. Muminov, E. Abduqodirov, H. Daminova, K. Khalimova, O. Naimov, R. Juraev (Tashkent, Uzbekistan)

    Objective: Evaluation of the role and value of a special computer program for early detection of PD in ambulatory settings Background: The first symptoms of…
  • 2023 International Congress

    Gender-Specific Classification Models for Parkinson’s Disease using Non-Motor Symptoms and DNA Methylation Data

    MZA. Ali, PSD. Dholaniya (Hyderabad, India)

    Objective: In Parkinson's disease (PD) non-motor symptoms often appear before the motor symptoms. Detecting and understanding these non-motor symptoms and their possible genetic or epigenetic…
  • 2023 International Congress

    Psychometric properties of the Neuropsychiatric Fluctuations Scale: preliminary results in patients with Parkinson’s disease

    C. Rodriguez-Blazquez, I. Debove, S. Murcia, A. Zenger, MM. Kurtis, E. Cubo, C. Falup-Pecurariu, KR. Chaudhuri, H. Reichmann, B. Falkenburger, S. Bostantjopoulou, P. Martinez-Martin, MJ. Forjaz, M. Bereau, P. Krack (Madrid, Spain)

    Objective: To assess the psychometric properties of the Neuropsychiatric Fluctuations Scale (NFS) [1] in patients with Parkinson’s disease (PD) Background: PD presents with non-motor symptoms…
  • 2023 International Congress

    Association between type 2 diabetes mellitus with parkinson’s disease and the increase of the severity of depression and anxiety in a mexican population

    AA. Herrera Ruiz, DR. Aguila Godinez, AJ. Hernández-Medrano, MA. Ruiz Mafud, A. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To compare the severity of depression and anxiety in PwP between those with T2D and those without T2D. Background: Parkinson's disease (PD) is the…
  • 2023 International Congress

    Clinical Prediction of GBA Carrier Status in Parkinson’s Disease

    J. Greenberg, K. Astudillo, S. Frucht, A. Flinker, G. Riboldi (New York, USA)

    Objective: To design a model for prediction of GBA carrier status based on clinical and demographic features in a cohort of PD patients. Background: Given…
  • 2023 International Congress

    Self-report vs. informant-report of problematic behaviors using the Huntington’s Disease-Behavioral Questionnaire

    S. Hughes, E. Churchill, G. Parkin, B. Culbert, A. Smirnova, A. Hall, P. Gilbert, J. Corey-Bloom (San Diego, USA)

    Objective: To examine the utility of a new behavioral measure, the Huntington’s Disease–Behavioral Questionnaire (HD-BQ) (Hughes et al, 2023), in individuals with Huntington’s disease (HD).…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley